Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
120,781,538
-
Total 13F shares
-
9,850,113
-
Share change
-
+9,849,428
-
Total reported value
-
$157,559,817
-
Price per share
-
$16.32
-
Number of holders
-
37
-
Value change
-
+$157,548,817
-
Number of buys
-
36
Institutional Holders of Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS) as of Q4 2014
As of 31 Dec 2014,
Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,850,113 shares.
The largest 10 holders included
Kohlberg Kravis Roberts & Co. L.P., RA CAPITAL MANAGEMENT, LLC, FMR LLC, VHCP Management, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, BROWN ADVISORY INC, and Cormorant Asset Management, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.